- T J Nurmikko, consultant in pain relief,
- T P Nash, consultant in pain relief,
- J R Wiles, consultant in pain relief.
- Walton Centre for Neurology and Neurosurgery NHS Trust, Liverpool L9 1AE
- Correspondence to: Dr Nurmikko
The most important clinical development in chronic pain during the past decade has not been new treatments but a thoroughly revised interpretation of the mechanisms that act to maintain pain. Pain is no more seen as a predetermined result of simple activation of certain neural structures. It is now understood to be a dynamic phenomenon due to myriad pathophysiological changes in the peripheral and central nervous system in response to disease, injury, or loss of function1 (box 1). These changes reflect the surprising but indisputable fact that the human nervous system is adaptable and capable of substantial plasticity. Initially reversible, the changes tend to become fixed depending on the nature and duration of the original cause, as well as the age and perhaps the genetic susceptibility of the patient
In chronic pain the abnormal activity in the altered pain mediating afferent system continues irrespective of its original causation. Simple blocking or severing of neural pathways is not helpful: the locus of abnormal barrages is simply shifted more centrally. Recent advances in the pharmacology of pain have unravelled some of the mediators of chronic pain, and they offer potential targets for treatments that are currently being developed (box 2). New investigative techniques are also being developed for improved detection of factors maintaining chronic pain. Alongside pharmacological advances, stimulation treatments and psychological approaches have seen innovative developments.
Recent advances
Chronic pain is now known to be maintained by several pathophysiological mechanisms which currently can be dealt with only partially
New generation non-steroidal anti-inflammatory drugs have been developed for the treatment of rheumatic pain, but their true potential awaits the test of time
Choices for the treatment of neuropathic pain have increased with the advent of new anticonvulsants and topical agents
Indications for spinal cord stimulation have widened and include chronic angina and peripheral …
Sign in
Personal subscribers, sign in here:
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Evidence Based Medicine-Boondoggle?
Published 8 February 2012
Wills and wishes in organ donation
Published 8 February 2012
Re: Lessons from America
Published 8 February 2012
Boosting the role of low-molecular-weight heparins in primary PCI
Published 8 February 2012
Re: Should UK membership exams be held overseas? Yes
Published 8 February 2012
Most responses
Does anyone understand the government’s plan for the NHS? (17 responses)
Published 17 Jan 2012
Bad medicine: medical nutrition (15 responses)
Published 18 Jan 2012
Wakefield sues BMJ over MMR articles (5 responses)
Published 10 Jan 2012
Search for evidence goes on (5 responses)
Published 17 Jan 2012
How much of a social media profile can doctors have? (5 responses)
Published 23 Jan 2012